Invenomic Fund Investor Class shares BIVRX:NASDAQ

Net Asset Value$23.52Previous Close - 6/30/2022
1-Day Change-0.24(1.01%)
YTD Change+6.27(36.35%)

Growth of $10,000 Since Fund Inception

View portfolioPortfolio as of 01/31/2022

Top 5 SectorsTop 5 Holdings
Consumer Services11.28%
First American Government O...4.89%
Non-Energy Minerals5.55%
Dropbox Inc ORD3.04%
Process Industries4.71%
Stride Inc ORD2.80%
Distribution Services4.24%
H & R Block Inc ORD2.73%
Other3.13%
Bayer AG ORD2.60%
Concentration of Top 528.91% Concentration of Top 516.06% 

Fund Profile

Fund Strategy

The Fund seeks long term capital appreciation. It invest primarily in both long and short positions in equity securities principally traded in US markets. The Sub-Adviser seeks to be fully invested in the long portfolio, while allowing the size of the short portfolio to fluctuate based on the market opportunity.

Fund Category Sector Equity
Inception Date 06/19/2017
Manager Motamed/Deschaine
Fund Classification Alternative Long/Short Eqty Fds
Managed Since 2017
Other Managed Funds   BIVIX  BIVSX

Lipper Leader Scorecard as of 05/31/2022

RatingTotal
Return
Consistent
Return
PreservationTax
Efficiency
Expense*
Overall Rating(# of funds in category)
207

206

12,373

207

37
3 Year Rating(# of funds in category)
207

206

12,373

207

37
5 Year Rating(# of funds in category)
N/A

N/A

N/A

N/A

N/A
10 Year Rating(# of funds in category)
N/A

N/A

N/A

N/A

N/A

Fund Highlights

Total Expense Ratio2.48%
Average Market Capitallization$11.8 B
Net Asset ValueN/A
Total Net Assets$117.5 M
Sales ExpensesLevel Load Fund
Minimum Initial Investment$5000
Minimum IRA Investment$1000
AvailabilityClosed To New Investors
Current Yield0.00%
Dividend Ex-DateN/A

Risk Analysis

Beta vs. S&P 5000.26
R-Squared vs. S&P 5000.04
Standard Deviation23.38%
Sharpe Ratio1.61
Portfolio TurnoverN/A